No rival in the CIS
By Veronika Pimenova
The innovation allows doctors to save time and costs in diagnosing cancers. It can be used to monitor and localise cancer tumours during surgical operations and negates the need for repeated surgical intervention, enhancing patients’ recovery. The new device registers tissue fluorescence under the influence of laser irradiation. “Molecules in human tissue are highly fluorescent in the ultra-violet, visible and near infra-red range of the spectrum,” explain the specialists. “Cancer tumours have a different fluorescence, so are easily spotted; we can use the device to study the disease.”
The major advantage of the new technology is that it uses sources of light which are safe for patients. Additionally, it is highly accurate, speedy and allows us to conduct research in tissues with plenty of blood vessels. No similar device exists within the CIS and, in future, it could help develop new optic methods of cancer tumour diagnostics. Doctors will be able to receive unique information about various optic characteristics of tumour tissue and identify them more accurately.